Yahoo
OTC Markets OTCPK - Delayed Quote USD

RavenQuest BioMed Inc. (RVVQF)

0.0000 0.0000 (0.00%)
At close: October 30 at 5:00:00 PM EDT
Chart Range Bar
Loading chart for RVVQF
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0000
  • Volume 65,260
  • Avg. Volume 11
  • Market Cap (intraday) 1,236
  • Beta (5Y Monthly) 0.91
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada.

--

Full Time Employees

October 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RVVQF
0.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

RVVQF
0.00%
S&P 500 (^GSPC)
11.11%

3-Year Return

RVVQF
0.00%
S&P 500 (^GSPC)
81.91%

5-Year Return

RVVQF
90.00%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY18
Revenue 171.85k
Earnings --
Profit Margin 0.00%

Q3

FY18

0
50K
100K
150K
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -18.85%

  • Return on Equity (ttm)

    -112.46%

  • Revenue (ttm)

    1.52M

  • Net Income Avi to Common (ttm)

    -32.35M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    749.13k

  • Total Debt/Equity (mrq)

    71.99%

  • Levered Free Cash Flow (ttm)

    -3.3M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: